In a second criminal case against a pharmaceutical distributor and its executives this year, the Department of Justice has accused Ohio-based Miami-Luken and its former President and Compliance Officer of conspiring to...more
9/6/2019
/ Controlled Substances ,
Criminal Prosecution ,
DEA ,
Department of Justice (DOJ) ,
Distributors ,
Drug & Alcohol Abuse ,
Government Investigations ,
Internal Controls ,
Opioid ,
Pharmacies ,
Physicians ,
Prescription Drugs ,
Unjust Enrichment
Rochester Drug Co-Operative, Inc. (“RDC”), one of the 10 largest pharmaceutical distributors in the United States, was recently charged along with its former Chief Executive Officer and former Chief Compliance Officer, for...more
5/28/2019
/ CCO ,
CEOs ,
Compliance ,
Controlled Substances ,
Controlled Substances Act ,
Corporate Executives ,
Criminal Conspiracy ,
Criminal Investigations ,
DEA ,
Deferred Prosecution Agreements ,
Drug Distribution ,
New Guidance ,
Opioid ,
Personal Liability ,
Pharmaceutical Industry ,
Pharmacies ,
Unlawful Distribution